We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

17 hedge funds and large institutions have $145K invested in Yield10 Bioscience, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

13% more funds holding

Funds holding: 15 → 17 (+2)

30% less capital invested

Capital invested by funds: $206K → $145K (-$61.9K)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$5.75K
2
XT
XTX Topco
Cayman Islands
+$3.98K
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.96K
4
HF
HRT Financial
New York
+$465

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$6.24K
2
Citadel Advisors
Citadel Advisors
Florida
-$4.56K
3
WAM
Warberg Asset Management
Illinois
-$4.28K
4
TSS
Two Sigma Securities
New York
-$3.99K
5
CC
Cannell & Co
New York
-$2.97K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Cannell & Co
New York
$59.5K -$2.97K -447 -4%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$15K – – –
CCB
3
Cutter & Co Brokerage
Missouri
$12K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$9.68K – – –
VF
5
Virtu Financial
New York
$9K +$5.75K +866 +135%
Millennium Management
6
Millennium Management
New York
$7.86K -$6.24K -939 -41%
BlackRock
7
BlackRock
New York
$7.51K – – –
WAM
8
Warberg Asset Management
Illinois
$6.12K -$4.28K -645 -38%
BC
9
Birchview Capital
Vermont
$4.49K – – –
XT
10
XTX Topco
Cayman Islands
$3.46K +$3.98K +600 New
Renaissance Technologies
11
Renaissance Technologies
New York
$3K +$3.96K +596 New
TRCT
12
Tower Research Capital (TRC)
New York
$2.46K -$46 -7 -2%
Citadel Advisors
13
Citadel Advisors
Florida
$2.42K -$4.56K -686 -62%
HF
14
HRT Financial
New York
$2K +$465 +70 +16%
Wells Fargo
15
Wells Fargo
California
$9 -$7 -1 -33%
IA
16
IFP Advisors
Florida
$7 – – –
VL
17
Vima LLC
Michigan
$3 +$7 +1 New
SIC
18
Salem Investment Counselors
North Carolina
$1 – – –
TSS
19
Two Sigma Securities
New York
– -$3.99K -509 Closed
JP Morgan Chase
20
JP Morgan Chase
New York
– -$2 – –

YTEN Hedge Fund Activity: Q4 2023 in Review

17 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2023, worth a combined $145K — down 30% from $206K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new YTEN positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 6 trimmed.

The largest buyer was Virtu Financial, adding an estimated $5.75K. The largest seller was Millennium Management, cutting an estimated $6.24K.

  • 17 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2023, up from 15 in Q3 2023.
  • Funds reported $145K of Yield10 Bioscience, Inc. Common Stock stock for Q4 2023, down 30% quarter-over-quarter.
  • 3 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2023 and 1 closed out, a net change of +2 holders.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2023 was Virtu Financial, an estimated $5.75K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2023 was Millennium Management, an estimated $6.24K sold.

Based on aggregated 13F filings for Q4 2023.